Clinical Trial Update: A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1b/Phase 2 trial of SR419 in peripheral neuropathic pain, evaluating efficacy, safety, tolerability, and pharmacokinetics; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathic Pain

Drugs mentioned

• SR419

Snippet

Sponsor: Shanghai SIMR Biotechnology Co., Ltd. | Conditions: Peripheral Neuropathic Pain | Phase 1, Phase 2 | Status: COMPLETED